Page last updated: 2024-08-23

silybin and sb 202190

silybin has been researched along with sb 202190 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Danilenko, M; Studzinski, GP; Thompson, T; Vassilev, L	1

Other Studies

1 other study(ies) available for silybin and sb 202190

Article	Year
Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants. Cancer biology & therapy, 2010, Aug-15, Volume: 10, Issue:4 Topics: Abietanes; Antioxidants; Apoptosis; Blotting, Western; Calcitriol; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; G1 Phase; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Plant Extracts; Pyridines; Silybin; Silymarin; Tumor Suppressor Protein p53	2010

Article

Year

Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.

Cancer biology & therapy, 2010, Aug-15, Volume: 10, Issue:4

Topics: Abietanes; Antioxidants; Apoptosis; Blotting, Western; Calcitriol; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; G1 Phase; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Plant Extracts; Pyridines; Silybin; Silymarin; Tumor Suppressor Protein p53

2010